In agreement, modulation of CDK9 has been recently shown as a promising strategy to hamper the transcriptional machinery in tumors types that are strictly dependent on aberrant transcription from tumor-driver oncogenes (Tibes and Bogenberger, 2019; Chou et al., 2020). Here, CDK9 is linked to neoplasm.